Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis.

Molecular therapy : the journal of the American Society of Gene Therapy2021Li JM, Yang DC, Oldham J, et al.

Study designOther primary literature

SubjectHuman & animal

Record checks

Study design: Other primary literature
Subject: Human & animal
Publication year: 2021
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 13 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsArginineArgininosuccinate SynthaseBleomycinCell MovementCell ProliferationCitrullinemiaFemaleFibroblastsGene Expression Regulation, EnzymologicHumansHydrolasesLungMaleMicePrimary Cell CultureProto-Oncogene Proteins c-metPulmonary FibrosisSTAT3 Transcription Factorsrc-Family Kinases

DOI 10.1016/j.ymthe.2021.01.028

PMID 33508432

View source →